Filing Details
- Accession Number:
- 0001209191-23-007567
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2023-02-07 16:50:03
- Reporting Period:
- 2022-12-31
- Accepted Time:
- 2023-02-07 16:50:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1641281 | Bolt Biotherapeutics Inc. | BOLT | Pharmaceutical Preparations (2834) | 472804636 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1724190 | P. William Quinn | C/O Bolt Biotherapeutics, Inc. 900 Chesapeake Drive Redwood City CA 94063 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-06-06 | 2,500 | $1.64 | 22,654 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-12-06 | 1,789 | $1.18 | 24,443 | No | 5 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | P | Direct | |
No | 5 | P | Direct |
Footnotes
- Shares acquired under the issuer's Employee Stock Purchase Plan.